Teva Pharmaceutical Industries Limited Stock
Stocks
TEVA
US8816242098
Pharmaceuticals
OTC Markets Traded|
Market Closed -
NYSE
00:00:03 10/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 36.85 USD | +0.24% |
|
+1.82% | +18.07% |
| 09-04 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 09-04 | Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data | MT |
| Market Cap | 42.84B 36.86B 34.71B 31.62B 59.17B 4,076B 59.41B 411B 159B 2,077B 161B 157B 6,579B | P/E 2026 * |
52.6x | P/E 2027 * | 21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 54.74B 47.1B 44.35B 40.41B 75.61B 5,209B 75.91B 526B 203B 2,654B 206B 201B 8,407B | EV / Sales 2026 * |
3.3x | EV / Sales 2027 * | 2.97x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| TEVA | Delayed | |
CBOE
| TEVA | Real-time | |
|
Tradegate
| TEV | Real-time | |
|
Boerse Muenchen
| TEV | Real-time | |
|
Deutsche Boerse AG
| TEV | Delayed | |
|
London S.E.
| 0LER | Delayed | |
|
Mexican S.E.
| TEVA N | End-of-day quote | |
|
Wiener Boerse
| TEVA | End-of-day quote | |
|
Börse Stuttgart
| TEV | Delayed |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | +0.24% | ||
| 1 week | +1.82% | ||
| Current month | +2.22% | ||
| 1 month | +4.21% | ||
| 3 months | +10.79% | ||
| 6 months | +18.68% | ||
| Current year | +18.07% |
| 1 week | 35.42 |  | 38.06 |
| 1 month | 35 | | 38.37 |
| Current year | 27.93 | | 38.37 |
| 1 year | 18.21 | | 38.37 |
| 3 years | 8.06 | | 38.37 |
| 5 years | 6.78 | | 38.37 |
| 10 years | 6.07 | | 52.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/08/26 | Sell | Controller/Auditor | -14,445 | 0.0012% | ||
| 21/08/26 | Sell | Director | -415 | 0.0000% | ||
| 17/08/26 | Sell | EVP, Business Development | -18,600 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.24% | +1.82% | +90.93% | +283.06% | 42.84B | |
| +0.03% | -3.09% | +52.20% | +91.69% | 1,002B | |
| -0.76% | -1.52% | +49.94% | +66.34% | 649B | |
| +0.86% | -3.49% | +19.60% | +68.37% | 440B | |
| -0.80% | +0.06% | +28.73% | +35.45% | 346B | |
| -0.13% | -14.74% | +9.13% | +26.71% | 263B | |
| -1.90% | -2.61% | -2.67% | +7.41% | 250B | |
| -0.48% | -10.69% | +39.64% | +50.82% | 213B | |
| -1.06% | -1.70% | -16.73% | -57.36% | 201B | |
| -0.68% | -2.85% | +25.69% | +91.64% | 182B | |
| Average | -0.45% | -1.70% | +29.65% | +66.41% | 358.65B | |
| Weighted average by Cap. | -0.34% | -2.34% | +33.07% | +59.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.6B 14.29B 13.45B 12.26B 22.93B 1,580B 23.02B 159B 61.62B 805B 62.34B 60.99B 2,550B | 17.32B 14.9B 14.03B 12.79B 23.92B 1,648B 24.02B 166B 64.27B 840B 65.03B 63.62B 2,660B |
| Net income | 1.27B 1.1B 1.03B 941M 1.76B 121B 1.77B 12.24B 4.73B 61.8B 4.79B 4.68B 196B | 2.43B 2.09B 1.97B 1.8B 3.36B 232B 3.37B 23.36B 9.03B 118B 9.14B 8.94B 374B |
| Net Debt | 11.9B 10.24B 9.64B 8.79B 16.44B 1,133B 16.51B 114B 44.17B 577B 44.69B 43.72B 1,828B | 8.65B 7.45B 7.01B 6.39B 11.95B 823B 12B 83.09B 32.11B 419B 32.49B 31.78B 1,329B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | $36.85 | +0.24% | 3,999,754 |
| 08/09/26 | $36.76 | +1.10% | 4,623,970 |
| 04/09/26 | $36.36 | -0.71% | 7,402,523 |
| 03/09/26 | $36.62 | -2.32% | 3,904,536 |
| 02/09/26 | $37.49 | +3.59% | 7,690,282 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
